AMBER YARRISON: Open Payments
NPI 1821555384 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,300 in 116 payments from 12 companies in 2025. Trend: 2023 $2,334 · 2024 $1,820 · 2025 $2,300
Food & beverage: $2,300
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $362 |
| Lilly USA, LLC | 16 | $296 |
| Amgen Inc. | 12 | $282 |
| AstraZeneca Pharmaceuticals LP | 12 | $258 |
| PFIZER INC. | 18 | $245 |
| Novo Nordisk Inc | 17 | $234 |
| Novartis Pharmaceuticals Corporation | 5 | $231 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $110 |
| Otsuka America Pharmaceutical, Inc. | 5 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $86 |
Products named: MOUNJARO, NURTEC ODT, LEQVIO, VRAYLAR, REPATHA, UBRELVY, Ozempic, Kerendia.
Industry payments across NC — which companies pay providers there.
